Introduction
Neftys Pharma, a leading European veterinary-pharmaceutical wholesaler, has acquired majority stake in DDL Zagreb, a Croatian wholesaler and retailer of veterinary-medical products, pet food and equipment. GRUBISIC KRESIC Corporate Finance acted as the exclusive financial advisor to the management and shareholders of DDL Zagreb in the transaction process.
Information about the Acquirer
Neftys Pharma is a distribution platform headquartered in France, specializing in animal health products. Since its founding in 1987, the company has established a strong international footprint, operating across 12 countries in Europe and Africa through 27 located sites. With a team of over 650 professionals, a client base of approximately 20,000, and annual revenues exceeding EUR 500 million, Neftys Pharma has emerged as a leading player in the veterinary healthcare distribution sector. In addition to its core wholesale business, Neftys Pharma provides customized supply chain solutions, serving a broad network of pharmacies, veterinary clinics, and veterinary healthcare professionals.
Information about the Target
Founded in 1991 and based in Zagreb, Croatia, DDL Zagreb is a well-established wholesaler of veterinary-medical products, pet food and supplements, and veterinary equipment. The company serves animal healthcare markets and has long-standing relationships and exclusive agreements with global manufacturers and healthcare providers. In addition to its wholesale operations, DDL Zagreb owns and operates Pet Home Shop, a specialized retail chain offering a wide range of pet food, accessories, and veterinary care products, further strengthening its footprint in the pet market. Through its subsidiaries, the company is also present in Serbia and Slovenia, collectively serving over 1,000 customers.
Transaction rationale
With this acquisition, Neftys Pharma marks its entry into Southeastern Europe, expanding its geographic footprint and reinforcing its veterinary distribution capabilities across Croatia, Slovenia, and Serbia. The transaction is expected to deliver significant commercial and operational synergies, further enhancing DDL’s competitive position in the dynamic and growing Adriatic markets.